XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.4
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Revenues $ 74,529 $ 61,403 $ 212,749 $ 156,163
Cost of revenues 51,677 45,077 144,970 112,000
Gross margin 22,852 16,326 67,779 44,163
Operating expenses:        
Research and development 3,543 3,000 11,577 7,932
Selling, general and administrative 15,440 11,567 43,051 30,990
Amortization of acquisition-related intangibles 510 444 1,184 1,289
Change in fair value 0 0 0 6,682
Total operating expenses 19,493 15,011 55,812 46,893
Operating income (loss) 3,359 [1] 1,315 [2] 11,967 [1] (2,730) [2]
Interest income, net 1,997 802 5,198 2,901
Other (expense)/income, net 77 272 57 (214)
Income (loss) before income tax benefit 5,433 2,389 17,222 (43)
Income tax benefit (112,373) (76) (112,058) (4,871)
Net income $ 117,806 $ 2,465 $ 129,280 $ 4,828
Net income per share of common stock        
Basic (in dollars per share) $ 2.68 $ 0.07 $ 3.08 $ 0.13
Diluted (in dollars per share) $ 2.62 $ 0.06 $ 3.01 $ 0.13
Weighted average number of shares of common stock outstanding        
Basic (in shares) 43,957 37,661 42,036 36,766
Diluted (in shares) 44,939 38,463 42,975 37,457
[1] The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker.
[2] The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker.